ArticleCancer medicine2026

Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single Center.

Lingxia Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.